Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome.
作者信息
Davin Jean-Claude, Groothoff Jaap, Gracchi Valentina, Bouts Antonia
出版信息
Pediatr Nephrol. 2011 Oct;26(10):1915-6. doi: 10.1007/s00467-011-1925-7. Epub 2011 Jun 7.
Abstract
摘要
相似文献
1
Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2011 Oct;26(10):1915-6. doi: 10.1007/s00467-011-1925-7. Epub 2011 Jun 7.
2
Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2011 Oct;26(10):1917-8. doi: 10.1007/s00467-011-1930-x. Epub 2011 Jun 7.
3
Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.依库珠单抗治疗肾移植后复发性非典型溶血性尿毒症综合征的疗效
Transplantation. 2010 Apr 15;89(7):903-4. doi: 10.1097/TP.0b013e3181ccd80d.
4
Eculizumab for congenital atypical hemolytic-uremic syndrome.依库珠单抗用于先天性非典型溶血性尿毒症综合征。
N Engl J Med. 2009 Jan 29;360(5):544-6. doi: 10.1056/NEJMc0809959.
5
Transplantation in atypical hemolytic uremic syndrome.非典型溶血性尿毒综合征的移植治疗。
Semin Thromb Hemost. 2010 Sep;36(6):653-9. doi: 10.1055/s-0030-1262887. Epub 2010 Sep 23.
6
[Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].[与补体系统异常相关的非典型溶血尿毒综合征]
Rev Med Interne. 2011 Apr;32(4):232-40. doi: 10.1016/j.revmed.2009.09.039. Epub 2011 Mar 3.
7
Eculizumab for atypical hemolytic-uremic syndrome.依库珠单抗用于非典型溶血性尿毒症综合征
N Engl J Med. 2009 Jan 29;360(5):542-4. doi: 10.1056/NEJMc0808527.
8
Recent advances in the management of atypical hemolytic uremic syndrome.非典型溶血性尿毒症综合征治疗的最新进展
Clin Adv Hematol Oncol. 2012 Aug;10(8):537-9.
9
Update on evaluating complement in hemolytic uremic syndrome.溶血性尿毒症综合征中补体评估的最新进展。
Curr Opin Nephrol Hypertens. 2007 Nov;16(6):565-71. doi: 10.1097/MNH.0b013e3282f0872f.
10
Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.依库珠单抗治疗非典型溶血尿毒综合征：长期临床病程和组织学发现。
Pediatr Nephrol. 2011 Nov;26(11):2085-8. doi: 10.1007/s00467-011-1989-4. Epub 2011 Aug 30.
引用本文的文献
1
Hemolytic uremic syndrome in a developing country: Consensus guidelines.发展中国家溶血尿毒综合征：共识指南。
Pediatr Nephrol. 2019 Aug;34(8):1465-1482. doi: 10.1007/s00467-019-04233-7. Epub 2019 Apr 15.
2
Advances and challenges in the management of complement-mediated thrombotic microangiopathies.补体介导的血栓性微血管病管理中的进展与挑战
Ther Adv Hematol. 2015 Aug;6(4):171-85. doi: 10.1177/2040620715577613.
3
Complement factor H mutation associated with membranoproliferative glomerulonephritis with transformation to atypical haemolytic uraemic syndrome.与膜增生性肾小球肾炎相关的补体因子H突变并转化为非典型溶血性尿毒症综合征。
Clin Kidney J. 2013 Apr;6(2):216-219. doi: 10.1093/ckj/sfs190. Epub 2013 Feb 5.
4
Optimizing treatment strategies in paediatric atypical hemolytic uremic syndrome.
Pediatr Nephrol. 2011 Oct;26(10):1917-8. doi: 10.1007/s00467-011-1930-x. Epub 2011 Jun 7.
本文引用的文献
1
aHUS caused by complement dysregulation: new therapies on the horizon.补体失调导致的 aHUS：新的治疗方法即将出现。
Pediatr Nephrol. 2011 Jan;26(1):41-57. doi: 10.1007/s00467-010-1556-4. Epub 2010 Jun 18.
2
Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.腹泻阴性溶血性尿毒症综合征的调查与初始治疗指南
Pediatr Nephrol. 2009 Apr;24(4):687-96. doi: 10.1007/s00467-008-0964-1. Epub 2008 Sep 18.
3
Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation.非典型溶血性尿毒症综合征的血浆疗法：来自一个伴有补体因子H突变家族的经验教训
Pediatr Nephrol. 2008 Sep;23(9):1517-21. doi: 10.1007/s00467-008-0833-y. Epub 2008 May 16.
4
Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchanges and ganciclovir.移植后巨细胞病毒诱导的伴有H因子突变的非典型溶血性尿毒症综合征复发：强化血浆置换和更昔洛韦治疗成功
Am J Kidney Dis. 2005 Jan;45(1):e12-5. doi: 10.1053/j.ajkd.2004.09.012.
Zotero 插件